Sabuya, Jose L.

HRN: 19-02-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2023
CEFTRIAXONE 1G (VIAL)
10/21/2023
10/28/2023
IV
2g
Daily
Indirect InguinalHernia, Right, Irreducible; Hydrocele, Right; S/P Herniorrhaphy (March 2020, MRH)
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: